DataLookout syncs with ClinicalTrials.gov every day, compares trial records field-by-field against yesterday's snapshot, and surfaces the changes that matter. Status shifts, phase transitions, enrollment updates, and new filings — delivered to your dashboard and inbox without manual checking.
Start Monitoring Free →Most pharma teams still track competitor trials by hand. DataLookout replaces that workflow with daily automated change detection.
Every morning, DataLookout compares thirteen fields on each trial record against the prior day's snapshot and flags the differences. It also flags new trials when a sponsor on your watchlist files one.
Recruiting to completed, suspended, or withdrawn. Know the next morning when a competitor's trial stops enrolling or reaches a milestone.
Phase 1 to Phase 2, Phase 2 to Phase 3. Track when trials advance through clinical development stages.
Target enrollment increases or decreases. A sudden jump in target enrollment often signals expanded indications or positive interim data.
Primary or secondary endpoint changes. Endpoint shifts can indicate protocol amendments or regulatory feedback.
New study locations added to a trial. Geographic expansion reveals where a sponsor is scaling their clinical operations.
When a sponsor on your watchlist files a new trial on ClinicalTrials.gov. Know about a competitor's new filing before it appears in any news feed.
Add the sponsors and disease areas you want to monitor. Search across 150,000+ trials from ClinicalTrials.gov.
Every day, DataLookout syncs trial data, compares records field-by-field, and classifies changes by severity.
View changes on your dashboard or receive email digests. Status changes, phase transitions, new filings — all in one place.
Clinical trial monitoring software, in the competitive intelligence sense, means automated tracking of the public trial landscape. It is not the same as monitoring the conduct of a trial you are running. The goal is to know, as soon as possible, when a competitor registers a new study, when a Phase 2 advances to Phase 3, when a trial is terminated, or when a new entrant files in your therapeutic area.
ClinicalTrials.gov publishes the underlying records and offers RSS feeds for new and updated studies, so the raw signal is public and free. What it does not do is tell you which field changed and what it changed from, or roll that up across a set of sponsors and diseases. Making that comparison is the work monitoring software does.
DataLookout automates that layer. You choose the sponsors, disease areas and searches you care about, and it sends a daily digest of what changed, with the old and new value on each change.
Track competitor pipeline entries and Phase 2/3 transitions. Know when a potential licensing target has a new study before your competitors do.
Maintain a live map of every company working in your space. Filter by sponsor, phase, and status. Build the landscape once and keep it current.
Monitor relevant disease areas for new investigator-initiated trials, academic partnerships, and NIH-sponsored programs that inform your evidence generation strategy.
See it in your digest when portfolio companies update their trial status, or when a competitor's trial is terminated. Trial registry changes are material, so know them the next morning.
The two most common approaches to clinical trial monitoring are ClinicalTrials.gov itself and enterprise intelligence platforms. DataLookout occupies the gap between them.
| Approach | Cost | Daily coverage | Setup time | How you are notified |
|---|---|---|---|---|
| ClinicalTrials.gov directly | Free | Yes, RSS feeds for new and updated studies | Manual filter setup | RSS feed you subscribe to. Says a record changed, not which field |
| Citeline / GlobalData | No public price | Yes | Demo or specialist request | Not mentioned on the product page |
| Build internal pipeline | Engineering time | Yes (if maintained) | Months | Custom build |
| DataLookout | free plan, then $49 to $149/month | Yes, every morning | 2 minutes | Daily or weekly email digest, with the old and new value |
Some engineering-forward biotech and pharma teams have built internal scrapers against the ClinicalTrials.gov API. It works, until the API changes, or the engineer who built it leaves, or the cron job silently fails for three months.
DataLookout maintains the pipeline, handles API changes, monitors for failures, and sends the daily digest reliably. Building and maintaining this infrastructure costs engineering time that most biotech teams do not want to spend on internal tooling. We handle it from $49/month.